相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
Jamaal A. Rehman et al.
MODERN PATHOLOGY (2017)
Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer
Y. Asano et al.
BRITISH JOURNAL OF SURGERY (2016)
Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors
Camille Petrau et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
Minoru Miyashita et al.
BREAST CANCER RESEARCH (2015)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
A. N. Seo et al.
BRITISH JOURNAL OF CANCER (2013)
Analytical and clinical evaluation of biomarkers assays: When are biomarkers ready for prime time?
Gene A. Pennello
CLINICAL TRIALS (2013)
Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility
Lisa M. McShane et al.
CLINICAL TRIALS (2013)
Sample size and threshold estimation for clinical trials with predictive biomarkers
Howard M. Mackey et al.
CONTEMPORARY CLINICAL TRIALS (2013)
An industry statistician's perspective on PHC drug development
Jane Fridlyand et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Hee Jin Lee et al.
JOURNAL OF BREAST CANCER (2013)
Considerations for the successful co-development of targeted cancer therapies and companion diagnostics
Jane Fridlyand et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Automatic Nuclei Segmentation in H&E Stained Breast Cancer Histopathology Images
Mitko Veta et al.
PLOS ONE (2013)
FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
Eliane C. M. Zeestraten et al.
CANCER MICROENVIRONMENT (2013)
Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Implications for Powering Biomarker Discovery Studies
Sian M. Dibben et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Leukocyte composition of human breast cancer
Brian Ruffell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CD8+ T lymphocytes infiltrating breast cancer A promising new prognostic marker?
Sahar Mahmoud et al.
ONCOIMMUNOLOGY (2012)
CD8(+) lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
Shuzhen Liu et al.
BREAST CANCER RESEARCH (2012)
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
Niels Halama et al.
CANCER RESEARCH (2011)
Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent
Mobolaji O. Olurinde et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer
Gavin W. A. Lamb et al.
BJU INTERNATIONAL (2008)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma
E. Richardsen et al.
HISTOPATHOLOGY (2008)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transient expression of FOXP3 in human activated nonregulatory CD4(+) T cells
Jun Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Christoph Loddenkemper et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
K Hiraoka et al.
BRITISH JOURNAL OF CANCER (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients
M van Oijen et al.
CLINICAL CANCER RESEARCH (2004)
CD8(+) tumor-infiltrating lymphocytes together with CD4(+) tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
A Fukunaga et al.
PANCREAS (2004)
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
EJ Bromwich et al.
BRITISH JOURNAL OF CANCER (2003)
Clinical significance of immune cell infiltration within gallbladder cancer
Y Nakakubo et al.
BRITISH JOURNAL OF CANCER (2003)
Automated selection of DAB-labeled tissue for immunohistochemical quantification
EM Brey et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
CD4(+) T cells in cancer stroma, not CD8(+) T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers
O Wakabayashi et al.
CANCER SCIENCE (2003)
Deeper examination of negative colorectal biopsies
MLC Wu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2002)
分享论文
